Celldex Therapeutics Inc
NASDAQ:CLDX
Celldex Therapeutics Inc
NASDAQ:CLDX
Price:
33.32
USD
-3.11%
Market Cap:
$2.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
US |
|
UL Solutions Inc
F:72R
|
US |
|
C
|
Continental AG
XBER:CON
|
DE |
|
B
|
Brunswick Corp
XMUN:BWI
|
US |
|
V
|
Vulcan Materials Co
DUS:VMC
|
US |
|
F
|
Fortune Brands Home & Security Inc
F:2FB
|
US |
|
C
|
China Merchants Port Holdings Co Ltd
XMUN:CPM
|
HK |
Wall St Price Targets
CLDX Price Targets Summary
Celldex Therapeutics Inc
Celldex Therapeutics Inc
Wall Street analysts forecast CLDX stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for CLDX is 56.85 USD with a low forecast of 34.34 USD and a high forecast of 94.5 USD.
Lowest Forecast
Price Target
34.34
USD
3% Upside
Average Forecast
Price Target
56.85
USD
71% Upside
Highest Forecast
Price Target
94.5
USD
184% Upside
Celldex Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CLDX's stock price target?
Price Target
56.85
USD
56.85
USD
According to Wall Street analysts, the average 1-year price target for CLDX is 56.85 USD with a low forecast of 34.34 USD and a high forecast of 94.5 USD.
What is the Revenue forecast for Celldex Therapeutics Inc?
Projected CAGR
147%
147%
Over the last 14 years, the compound annual growth rate for Revenue has been -12%. The projected CAGR for the next 8 years is 147%.
